推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Letters in Drug Design & Discovery

2023年12月最新中科院分区表数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 LETT DRUG DES D最新评论:你好,我想问下催告信发给谁啊 ,没有编辑的邮箱啊 (2023-05-18)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


Letters in Drug Design & Discovery期刊基本信息Hello,您是该期刊的第38492位访客

基本信息 登录收藏
期刊名字Letters in Drug Design & DiscoveryLetters in Drug Design & Discovery

LETT DRUG DES DISCOV
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
5.1
51人评分
我要评分

声誉
6.4

影响力
3.7

速度
7.0

期刊ISSN1570-1808
微信扫码收藏此期刊
2022-2023最新影响因子
(数据来源于搜索引擎)
1 点击查看影响因子趋势图
实时影响因子 截止2023年12月27日:0.978
2022-2023自引率10.00%点击查看自引率趋势图
五年影响因子1
h-index 28
CiteScore
CiteScoreSJRSNIPCiteScore排名
1.900.1920.293
学科分区排名百分位
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Pharmaceutical Science
Q397 / 171
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Drug Discovery
Q4120 / 156
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Molecular Medicine
Q4146 / 171

期刊简介
Aims & Scope

Letters in Drug Design & Discovery publishes letters, mini-reviews, highlights and guest edited thematic issues in all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. The emphasis is on publishing quality papers very rapidly by taking full advantage of latest Internet technology for both submission and review of manuscripts. The online journal is an essential reading to all pharmaceutical scientists involved in research in drug design and discovery.
期刊官方网站http://benthamscience.com/journal/index.php?journalID=lddd
期刊投稿网址http://benthamscience.com/journals/letters-in-drug-design-and-discovery/submit-abstracts-online/#top
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Letters in Drug Design & Discovery的语言要求,还能让Letters in Drug Design & Discovery编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Letters in Drug Design & Discovery编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR
出版商Bentham Science Publishers B.V.
涉及的研究方向医学-医药化学
出版国家或地区UNITED STATES
出版语言English
出版周期Bimonthly
出版年份2004
年文章数 87点击查看年文章数趋势图
Gold OA文章占比0.00%
研究类文章占比:
文章 ÷(文章 + 综述)
95.40%
WOS期刊SCI分区
2022-2023年最新版
WOS分区等级:4区

按学科分区JIF分区JIF排名JIF百分位
学科:CHEMISTRY, MEDICINAL
类别:SCIE
Q457/60
中科院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中科院SCI期刊分区
2023年12月最新升级版
点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 3区4区4区
CHEMISTRY, MEDICINAL
药物化学
3区4区4区
中科院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 2区4区3区
CHEMISTRY, MEDICINAL
药物化学
4区3区4区
中科院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 3区4区4区
CHEMISTRY, MEDICINAL
药物化学
4区4区4区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1570-1808%5BISSN%5D
平均审稿速度网友分享经验:
平均3.0个月
平均录用比例网友分享经验:
容易
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Letters in Drug Design & Discovery顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 Letters in Drug Design & Discovery期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Letters in Drug Design & Discovery中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Letters in Drug Design & Discovery上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    JOURNAL OF MEDICINAL CHEMISTRY24012.30
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY13512.10
    Marine Drugs849.60
    MINI-REVIEWS IN MEDICINAL CHEMISTRY797.10
    CURRENT TOPICS IN MEDICINAL CHEMISTRY1046.60
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS1335.50
    MEDICINAL CHEMISTRY RESEARCH384.30
    Medicinal Chemistry394.00
    NATURAL PRODUCT RESEARCH424.50
    Records of Natural Products243.10
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE599603
    BIOMATERIALS512488
    BIOMEDICINE & PHARMACOTHERAPY461557
    Journal of Materials Chemistry B458228
    Frontiers in Pharmacology447997
    Frontiers in Immunology418857
    JOURNAL OF ETHNOPHARMACOLOGY403344
    COLLOIDS AND SURFACES B-BIOINTERFACES402965
    Frontiers in Oncology382298
    Acta Biomaterialia374439
  •  

    Letters in Drug Design & Discovery Letters in Drug Design & Discovery
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Design, Synthesis, and Insecticidal Evaluation of New Benzoylureas Containing Carbamate Groups Based on the Bipartite Model of Sulfonylurea Receptor Binding Site

    Author: Zhang, Jingjing; Zhu, Hualing; Xiong, Lixia; Shi, Jun; Huang, Zhiqiang
    Journal: LETTERS IN DRUG DESIGN & DISCOVERY. 2023; Vol. 20, Issue 1, pp. 110-118. DOI: 10.2174/1570180819666220512182621
        DOI
    2.Design, Synthesis, and Anti-Bacterial Evaluation of Tetrahydrobenzothiophene Derivatives as Lipopolysaccharide Biogenesis Inhibitors

    Author: Pei, Shuchen; Yang, Jinhua; Xia, Shihao; Tang, Shuting; Yuan, Kangyao; Chen, Jun
    Journal: LETTERS IN DRUG DESIGN & DISCOVERY. 2023; Vol. 20, Issue 3, pp. 335-342. DOI: 10.2174/1570180819666220317151208
        DOI
    3.Molecular Mechanism of Qingchang Suppository in the Treatment of Ulcerative Colitis Based on Network Pharmacology

    Author: Lin, Zhancheng; Lu, Lu; Zhu, Lingyu
    Journal: LETTERS IN DRUG DESIGN & DISCOVERY. 2023; Vol. 20, Issue 1, pp. 71-76. DOI: 10.2174/1570180819666220509070003
        DOI
    4.Synthesis and Preliminary Biological Evaluation of New Phthalazinone Derivatives with PARP-1 and Cholinesterase Inhibitory Activities

    Author: Lin, Yu; Gao, Chengzhi; Wang, Zhuyong; Zhang, Ruifeng; Chen, Yajun; Min, Zhenli
    Journal: LETTERS IN DRUG DESIGN & DISCOVERY. 2023; Vol. 20, Issue 1, pp. 56-70. DOI: 10.2174/1570180819666220531144809
        DOI
    5.Oxymatrine-induced Apoptosis in Fibroblasts like Synoviocytes via Regulation of miR-146a/TRAF6/JNK1 Axis in Rheumatoid Arthritis

    Author: Li, Jing; Hong, Hua
    Journal: LETTERS IN DRUG DESIGN & DISCOVERY. 2023; Vol. 20, Issue 2, pp. 232-237. DOI: 10.2174/1570180819666220530143250
        DOI
    6.Design and Screening of KLHL22 Inhibitors by Homology Modeling, Molecular Docking, and Molecular Dynamics Simulation

    Author: Gao, Chenglong; Sun, Chuance; Zhang, Lichuan; Zhang, Haoran; Yu, Rilei; Kang, Congmin
    Journal: LETTERS IN DRUG DESIGN & DISCOVERY. 2023; Vol. 20, Issue 3, pp. 291-303. DOI: 10.2174/1570180819666220422101618
        DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    同分区等级的其他期刊名称 h-index CiteScore
    HARVARD BUSINESS REVIEW02.40
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE1086.10
    Energy Material Advances08.50
    CLINICAL AND EXPERIMENTAL HYPERTENSION453.60
    Journal of Public Transportation07.00
    Asian Journal of Psychiatry010.90
    Chinese Journal of Population Resources and Environment02.60
    VIEW08.60
    HLA933.00
    INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY011.50


以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

    同领域作者分享投稿经验:共3条 (包含回复)

我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海分公司    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960

    增值电信业务经营许可证:沪B2-20211595

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451